153 related articles for article (PubMed ID: 38841622)
21. Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.
Mazurakova A; Koklesova L; Samec M; Kudela E; Kajo K; Skuciova V; Csizmár SH; Mestanova V; Pec M; Adamkov M; Al-Ishaq RK; Smejkal K; Giordano FA; Büsselberg D; Biringer K; Golubnitschaja O; Kubatka P
EPMA J; 2022 Jun; 13(2):315-334. PubMed ID: 35437454
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
[TBL] [Abstract][Full Text] [Related]
23. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person.
Koklesova L; Mazurakova A; Samec M; Biringer K; Samuel SM; Büsselberg D; Kubatka P; Golubnitschaja O
EPMA J; 2021 Dec; 12(4):477-505. PubMed ID: 34786033
[TBL] [Abstract][Full Text] [Related]
24. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
[TBL] [Abstract][Full Text] [Related]
25. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine.
Zhang G; Wang Z; Song P; Zhan X
EPMA J; 2022 Dec; 13(4):649-669. PubMed ID: 36505890
[TBL] [Abstract][Full Text] [Related]
26. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine.
Liskova A; Samec M; Koklesova L; Kudela E; Kubatka P; Golubnitschaja O
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670490
[TBL] [Abstract][Full Text] [Related]
27. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
[TBL] [Abstract][Full Text] [Related]
29. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
30. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine.
Bi Q; Wu JY; Qiu XM; Li YQ; Yan YY; Sun ZJ; Wang W
EPMA J; 2023 Jun; 14(2):307-328. PubMed ID: 37275548
[TBL] [Abstract][Full Text] [Related]
32. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management.
Liskova A; Samec M; Koklesova L; Giordano FA; Kubatka P; Golubnitschaja O
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854390
[TBL] [Abstract][Full Text] [Related]
33. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.
Liskova A; Samec M; Koklesova L; Brockmueller A; Zhai K; Abdellatif B; Siddiqui M; Biringer K; Kudela E; Pec M; Gadanec LK; Šudomová M; Hassan STS; Zulli A; Shakibaei M; Giordano FA; Büsselberg D; Golubnitschaja O; Kubatka P
EPMA J; 2021 Jun; 12(2):155-176. PubMed ID: 34025826
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
[TBL] [Abstract][Full Text] [Related]
35. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G
EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829
[TBL] [Abstract][Full Text] [Related]
36. Social determinants of health and their relation to suboptimal health status in the context of 3PM: a latent profile analysis.
Tong LK; Li YY; Liu YB; Zheng MR; Fu GL; Au ML
EPMA J; 2024 Jun; 15(2):221-232. PubMed ID: 38841621
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors.
Yang L; Li C; Song T; Zhan X
EPMA J; 2023 Sep; 14(3):443-456. PubMed ID: 37605654
[TBL] [Abstract][Full Text] [Related]
38. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention.
Koklesova L; Liskova A; Samec M; Zhai K; Al-Ishaq RK; Bugos O; Šudomová M; Biringer K; Pec M; Adamkov M; Hassan STS; Saso L; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445360
[TBL] [Abstract][Full Text] [Related]
39. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare.
Zubor P; Dankova Z; Kolkova Z; Holubekova V; Brany D; Mersakova S; Samec M; Liskova A; Koklesova L; Kubatka P; Bujnak J; Kajo K; Mlyncek M; Giordano FA; Golubnitschaja O
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32443784
[TBL] [Abstract][Full Text] [Related]
40. Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.
Lučanský V; Holubeková V; Kolková Z; Halašová E; Samec M; Golubnitschaja O
EPMA J; 2023 Jun; 14(2):201-217. PubMed ID: 37275547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
